Cargando…

Sulfasalazine: a risk factor for severe COVID-19?

Detalles Bibliográficos
Autores principales: Konig, Maximilian F, Grzes, Katarzyna M, Robinson, Philip C, Pearce, Edward J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923673/
https://www.ncbi.nlm.nih.gov/pubmed/35310293
http://dx.doi.org/10.1016/S2665-9913(22)00067-4
_version_ 1784669707563958272
author Konig, Maximilian F
Grzes, Katarzyna M
Robinson, Philip C
Pearce, Edward J
author_facet Konig, Maximilian F
Grzes, Katarzyna M
Robinson, Philip C
Pearce, Edward J
author_sort Konig, Maximilian F
collection PubMed
description
format Online
Article
Text
id pubmed-8923673
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-89236732022-03-16 Sulfasalazine: a risk factor for severe COVID-19? Konig, Maximilian F Grzes, Katarzyna M Robinson, Philip C Pearce, Edward J Lancet Rheumatol Comment Elsevier Ltd. 2022-06 2022-03-15 /pmc/articles/PMC8923673/ /pubmed/35310293 http://dx.doi.org/10.1016/S2665-9913(22)00067-4 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Comment
Konig, Maximilian F
Grzes, Katarzyna M
Robinson, Philip C
Pearce, Edward J
Sulfasalazine: a risk factor for severe COVID-19?
title Sulfasalazine: a risk factor for severe COVID-19?
title_full Sulfasalazine: a risk factor for severe COVID-19?
title_fullStr Sulfasalazine: a risk factor for severe COVID-19?
title_full_unstemmed Sulfasalazine: a risk factor for severe COVID-19?
title_short Sulfasalazine: a risk factor for severe COVID-19?
title_sort sulfasalazine: a risk factor for severe covid-19?
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923673/
https://www.ncbi.nlm.nih.gov/pubmed/35310293
http://dx.doi.org/10.1016/S2665-9913(22)00067-4
work_keys_str_mv AT konigmaximilianf sulfasalazineariskfactorforseverecovid19
AT grzeskatarzynam sulfasalazineariskfactorforseverecovid19
AT robinsonphilipc sulfasalazineariskfactorforseverecovid19
AT pearceedwardj sulfasalazineariskfactorforseverecovid19